CHRONIC HEPATITIS B: CARG-201
- Functional cure for Chronic Hepatitis B patients
- Enables robust expression and secretion of Chronic Hepatitis B middle S and core antigens in vitro
- Induces broad immune responses
- Results in reduction of Chronic Hepatitis B marker surface antigens by more than 2 logs in AAV model
- Eliminates virus as monotherapy or in combination with standard antiviral therapy